nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzonatate—Nonoxynol-9—PTGS2—pancreatic cancer	0.173	1	CrCbGaD
Benzonatate—Numbness—Tamoxifen—pancreatic cancer	0.0386	0.0467	CcSEcCtD
Benzonatate—Sensory loss—Tamoxifen—pancreatic cancer	0.037	0.0447	CcSEcCtD
Benzonatate—Eruption—Gemcitabine—pancreatic cancer	0.0358	0.0433	CcSEcCtD
Benzonatate—Depressed level of consciousness—Sunitinib—pancreatic cancer	0.0265	0.032	CcSEcCtD
Benzonatate—Numbness—Fluorouracil—pancreatic cancer	0.0261	0.0316	CcSEcCtD
Benzonatate—Eruption—Docetaxel—pancreatic cancer	0.0254	0.0307	CcSEcCtD
Benzonatate—Sensory loss—Fluorouracil—pancreatic cancer	0.025	0.0302	CcSEcCtD
Benzonatate—Nasal congestion—Sunitinib—pancreatic cancer	0.0219	0.0264	CcSEcCtD
Benzonatate—Abdominal discomfort—Tamoxifen—pancreatic cancer	0.0193	0.0233	CcSEcCtD
Benzonatate—Eruption—Epirubicin—pancreatic cancer	0.0171	0.0207	CcSEcCtD
Benzonatate—Abdominal discomfort—Sunitinib—pancreatic cancer	0.0165	0.0199	CcSEcCtD
Benzonatate—Hypoaesthesia—Tamoxifen—pancreatic cancer	0.016	0.0193	CcSEcCtD
Benzonatate—Eruption—Doxorubicin—pancreatic cancer	0.0158	0.0192	CcSEcCtD
Benzonatate—Hypoaesthesia—Sunitinib—pancreatic cancer	0.0137	0.0166	CcSEcCtD
Benzonatate—Bronchospasm—Gemcitabine—pancreatic cancer	0.0136	0.0164	CcSEcCtD
Benzonatate—Shock—Erlotinib—pancreatic cancer	0.0111	0.0134	CcSEcCtD
Benzonatate—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.0108	0.0131	CcSEcCtD
Benzonatate—Convulsion—Sunitinib—pancreatic cancer	0.0104	0.0126	CcSEcCtD
Benzonatate—Constipation—Tamoxifen—pancreatic cancer	0.00977	0.0118	CcSEcCtD
Benzonatate—Constipation—Erlotinib—pancreatic cancer	0.00967	0.0117	CcSEcCtD
Benzonatate—Bronchospasm—Docetaxel—pancreatic cancer	0.00964	0.0117	CcSEcCtD
Benzonatate—Shock—Sunitinib—pancreatic cancer	0.00963	0.0116	CcSEcCtD
Benzonatate—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00842	0.0102	CcSEcCtD
Benzonatate—Constipation—Sunitinib—pancreatic cancer	0.00837	0.0101	CcSEcCtD
Benzonatate—Convulsion—Fluorouracil—pancreatic cancer	0.00819	0.00991	CcSEcCtD
Benzonatate—Confusional state—Irinotecan—pancreatic cancer	0.00813	0.00983	CcSEcCtD
Benzonatate—Pruritus—Tamoxifen—pancreatic cancer	0.00808	0.00977	CcSEcCtD
Benzonatate—Pruritus—Erlotinib—pancreatic cancer	0.008	0.00967	CcSEcCtD
Benzonatate—Shock—Irinotecan—pancreatic cancer	0.00793	0.00959	CcSEcCtD
Benzonatate—Hypoaesthesia—Docetaxel—pancreatic cancer	0.0078	0.00943	CcSEcCtD
Benzonatate—Confusional state—Fluorouracil—pancreatic cancer	0.00778	0.00941	CcSEcCtD
Benzonatate—Dizziness—Tamoxifen—pancreatic cancer	0.00755	0.00913	CcSEcCtD
Benzonatate—Dizziness—Erlotinib—pancreatic cancer	0.00747	0.00904	CcSEcCtD
Benzonatate—Hypersensitivity—Sunitinib—pancreatic cancer	0.00721	0.00872	CcSEcCtD
Benzonatate—Rash—Tamoxifen—pancreatic cancer	0.0072	0.00871	CcSEcCtD
Benzonatate—Headache—Tamoxifen—pancreatic cancer	0.00716	0.00865	CcSEcCtD
Benzonatate—Rash—Erlotinib—pancreatic cancer	0.00713	0.00862	CcSEcCtD
Benzonatate—Headache—Erlotinib—pancreatic cancer	0.00708	0.00856	CcSEcCtD
Benzonatate—Pruritus—Sunitinib—pancreatic cancer	0.00692	0.00837	CcSEcCtD
Benzonatate—Constipation—Irinotecan—pancreatic cancer	0.00689	0.00833	CcSEcCtD
Benzonatate—Nausea—Tamoxifen—pancreatic cancer	0.00679	0.0082	CcSEcCtD
Benzonatate—Constipation—Gemcitabine—pancreatic cancer	0.00671	0.00812	CcSEcCtD
Benzonatate—Nausea—Erlotinib—pancreatic cancer	0.00671	0.00812	CcSEcCtD
Benzonatate—Feeling abnormal—Irinotecan—pancreatic cancer	0.00664	0.00803	CcSEcCtD
Benzonatate—Dizziness—Sunitinib—pancreatic cancer	0.00647	0.00782	CcSEcCtD
Benzonatate—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00647	0.00782	CcSEcCtD
Benzonatate—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00636	0.00769	CcSEcCtD
Benzonatate—Rash—Sunitinib—pancreatic cancer	0.00617	0.00746	CcSEcCtD
Benzonatate—Headache—Sunitinib—pancreatic cancer	0.00613	0.00741	CcSEcCtD
Benzonatate—Hypersensitivity—Irinotecan—pancreatic cancer	0.00594	0.00718	CcSEcCtD
Benzonatate—Convulsion—Docetaxel—pancreatic cancer	0.00591	0.00715	CcSEcCtD
Benzonatate—Nausea—Sunitinib—pancreatic cancer	0.00581	0.00703	CcSEcCtD
Benzonatate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00569	0.00688	CcSEcCtD
Benzonatate—Confusional state—Docetaxel—pancreatic cancer	0.00562	0.00679	CcSEcCtD
Benzonatate—Pruritus—Gemcitabine—pancreatic cancer	0.00555	0.00672	CcSEcCtD
Benzonatate—Shock—Docetaxel—pancreatic cancer	0.00548	0.00663	CcSEcCtD
Benzonatate—Pruritus—Fluorouracil—pancreatic cancer	0.00546	0.0066	CcSEcCtD
Benzonatate—Dizziness—Irinotecan—pancreatic cancer	0.00533	0.00644	CcSEcCtD
Benzonatate—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00526	0.00636	CcSEcCtD
Benzonatate—Dizziness—Fluorouracil—pancreatic cancer	0.0051	0.00617	CcSEcCtD
Benzonatate—Rash—Irinotecan—pancreatic cancer	0.00508	0.00614	CcSEcCtD
Benzonatate—Headache—Irinotecan—pancreatic cancer	0.00505	0.0061	CcSEcCtD
Benzonatate—Rash—Gemcitabine—pancreatic cancer	0.00495	0.00599	CcSEcCtD
Benzonatate—Headache—Gemcitabine—pancreatic cancer	0.00492	0.00595	CcSEcCtD
Benzonatate—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.00487	0.00589	CcSEcCtD
Benzonatate—Rash—Fluorouracil—pancreatic cancer	0.00487	0.00588	CcSEcCtD
Benzonatate—Headache—Fluorouracil—pancreatic cancer	0.00484	0.00585	CcSEcCtD
Benzonatate—Nausea—Irinotecan—pancreatic cancer	0.00479	0.00579	CcSEcCtD
Benzonatate—Constipation—Docetaxel—pancreatic cancer	0.00476	0.00576	CcSEcCtD
Benzonatate—Nausea—Gemcitabine—pancreatic cancer	0.00466	0.00564	CcSEcCtD
Benzonatate—Feeling abnormal—Docetaxel—pancreatic cancer	0.00459	0.00555	CcSEcCtD
Benzonatate—Nausea—Fluorouracil—pancreatic cancer	0.00459	0.00554	CcSEcCtD
Benzonatate—Agitation—Epirubicin—pancreatic cancer	0.00423	0.00512	CcSEcCtD
Benzonatate—Hypersensitivity—Docetaxel—pancreatic cancer	0.0041	0.00496	CcSEcCtD
Benzonatate—Convulsion—Epirubicin—pancreatic cancer	0.00399	0.00482	CcSEcCtD
Benzonatate—Pruritus—Docetaxel—pancreatic cancer	0.00394	0.00477	CcSEcCtD
Benzonatate—Agitation—Doxorubicin—pancreatic cancer	0.00392	0.00473	CcSEcCtD
Benzonatate—Confusional state—Epirubicin—pancreatic cancer	0.00379	0.00458	CcSEcCtD
Benzonatate—Shock—Epirubicin—pancreatic cancer	0.0037	0.00447	CcSEcCtD
Benzonatate—Convulsion—Doxorubicin—pancreatic cancer	0.00369	0.00446	CcSEcCtD
Benzonatate—Dizziness—Docetaxel—pancreatic cancer	0.00368	0.00445	CcSEcCtD
Benzonatate—Rash—Docetaxel—pancreatic cancer	0.00351	0.00425	CcSEcCtD
Benzonatate—Confusional state—Doxorubicin—pancreatic cancer	0.00351	0.00424	CcSEcCtD
Benzonatate—Headache—Docetaxel—pancreatic cancer	0.00349	0.00422	CcSEcCtD
Benzonatate—Shock—Doxorubicin—pancreatic cancer	0.00342	0.00414	CcSEcCtD
Benzonatate—Nausea—Docetaxel—pancreatic cancer	0.00331	0.004	CcSEcCtD
Benzonatate—Constipation—Epirubicin—pancreatic cancer	0.00321	0.00389	CcSEcCtD
Benzonatate—Feeling abnormal—Epirubicin—pancreatic cancer	0.0031	0.00374	CcSEcCtD
Benzonatate—Constipation—Doxorubicin—pancreatic cancer	0.00297	0.0036	CcSEcCtD
Benzonatate—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00287	0.00346	CcSEcCtD
Benzonatate—Hypersensitivity—Epirubicin—pancreatic cancer	0.00277	0.00335	CcSEcCtD
Benzonatate—Pruritus—Epirubicin—pancreatic cancer	0.00266	0.00321	CcSEcCtD
Benzonatate—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00256	0.0031	CcSEcCtD
Benzonatate—Dizziness—Epirubicin—pancreatic cancer	0.00249	0.003	CcSEcCtD
Benzonatate—Pruritus—Doxorubicin—pancreatic cancer	0.00246	0.00297	CcSEcCtD
Benzonatate—Rash—Epirubicin—pancreatic cancer	0.00237	0.00286	CcSEcCtD
Benzonatate—Headache—Epirubicin—pancreatic cancer	0.00235	0.00285	CcSEcCtD
Benzonatate—Dizziness—Doxorubicin—pancreatic cancer	0.0023	0.00278	CcSEcCtD
Benzonatate—Nausea—Epirubicin—pancreatic cancer	0.00223	0.0027	CcSEcCtD
Benzonatate—Rash—Doxorubicin—pancreatic cancer	0.00219	0.00265	CcSEcCtD
Benzonatate—Headache—Doxorubicin—pancreatic cancer	0.00218	0.00263	CcSEcCtD
Benzonatate—Nausea—Doxorubicin—pancreatic cancer	0.00207	0.0025	CcSEcCtD
